LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to outperform chemo for advanced bladder cancer
Disease control OngoingThis phase 3 study tests whether a combination of two drugs, enfortumab vedotin and pembrolizumab, works better than standard chemotherapy for people with advanced urothelial cancer that has spread. About 886 participants who have not had prior treatment for their advanced cancer…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for advanced bladder cancer: experimental drug combo enters late-stage trial
Disease control OngoingThis study tests an experimental drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced urothelial cancer that has spread. The goal is to see if it works better than standard chemotherapy. About 375 participants will be enrolled, some who have not…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC